Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.15 | N/A |
PEG Ratio (TTM) | 0.27 | N/A |
P/S Ratio (TTM) | 24.94 | N/A |
P/B Ratio (TTM) | 0.97 | N/A |
P/FCF Ratio (TTM) | -2.52 | N/A |
Price to 5YR AVG Earnings Ratio | -5.51 | N/A |
Price to 5YR AVG FCF Ratio | -13.40 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -40.59% | N/A |
ROE (TTM) | -39.16% | N/A |
Net Profit Margin (TTM) | -1,042.84% | N/A |
ROIC 5YR AVG | -38.39% | N/A |
Growth (28%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -17.33% | -9.06% | 19.40% |
Revenue | 1.62% | 14.18% | 375.59% |
Net Income | -18.03% | -24.19% | 11.92% |
Cash Flow | -0.74% | -818.07% | -474.72% |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 14.33 | N/A |
Quick Ratio (TTM) | 14.33 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | -1,911.24 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | 4.85 | N/A |
LTL to 5YR AVG FCF | -0.18 | N/A |
Shares Outstanding Growth 5YR AVG | 9.52% | N/A |